Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
SMART: The MicroStent's ability to limit restenosis trial
Autore:
Heuser, R; Lopez, A; Kuntz, R; Reduto, L; Badger, R; Coleman, P; Whitlow, P; Iannone, LA; Safian, R; Yeung, A; Moses, J;
Indirizzi:
St Lukes Med Ctr, Phoenix Heart Ctr, Phoenix, AZ 85016 USA St Lukes Med Ctr Phoenix AZ USA 85016 ix Heart Ctr, Phoenix, AZ 85016 USA Beth Israel Hosp, Boston, MA USA Beth Israel Hosp Boston MA USABeth Israel Hosp, Boston, MA USA St Francis Hosp, Roslyn, NY USA St Francis Hosp Roslyn NY USASt Francis Hosp, Roslyn, NY USA Utah Valley Cardiol, Provo, UT USA Utah Valley Cardiol Provo UT USAUtah Valley Cardiol, Provo, UT USA No Calif Med Assoc, Santa Rosa, CA USA No Calif Med Assoc Santa Rosa CA USA Calif Med Assoc, Santa Rosa, CA USA Cleveland Clin, Cleveland, OH 44106 USA Cleveland Clin Cleveland OH USA 44106 eland Clin, Cleveland, OH 44106 USA Mercy Med Ctr, Des Moines, IA USA Mercy Med Ctr Des Moines IA USAMercy Med Ctr, Des Moines, IA USA William Beaumont Hosp, Royal Oak, MI 48072 USA William Beaumont Hosp Royal Oak MI USA 48072 osp, Royal Oak, MI 48072 USA Stanford Univ, Ctr Med, Stanford, CA 94305 USA Stanford Univ Stanford CA USA 94305 Univ, Ctr Med, Stanford, CA 94305 USA Lenox Hill Hosp, New York, NY 10021 USA Lenox Hill Hosp New York NY USA 10021 x Hill Hosp, New York, NY 10021 USA
Titolo Testata:
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
fascicolo: 3, volume: 52, anno: 2001,
pagine: 269 - 277
SICI:
1522-1946(200103)52:3<269:STMATL>2.0.ZU;2-M
Fonte:
ISI
Lingua:
ENG
Soggetto:
CORONARY-ARTERY DISEASE; BALLOON ANGIOPLASTY; INTRAVASCULAR ULTRASOUND; STENT PLACEMENT; LESION; MODEL;
Keywords:
coronary artery disease; vessels; coronary stents; revascularization; restenosis;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
18
Recensione:
Indirizzi per estratti:
Indirizzo: Heuser, R St Lukes Med Ctr, Phoenix Heart Ctr, 525 N 18th St,Suite 301, Phoenix, AZ 85016 USA St Lukes Med Ctr 525 N 18th St,Suite 301 Phoenix AZ USA85016 SA
Citazione:
R. Heuser et al., "SMART: The MicroStent's ability to limit restenosis trial", CATHET C IN, 52(3), 2001, pp. 269-277

Abstract

In this randomized, prospective, multicenter trial (n = 661) of patients with de novo or restenotic coronary lesions, 330 patients received the MicroStent(R) II (MSII), and 331 received the Palmaz-Schatz(R) (PS) stent. The short-term procedural success rates were 94.4% and 95.7%, respectively (P = 0.47). The 30-day cumulative incidence of major adverse events [death, myocardial infarction, CVA, target lesion revascularization (TLR)] was 6.4% forthe MSII and 4.5% for the PS stent (P = 0.31). The in-stent binary restenosis rate at 6 months was 25.2% for the MSII and 22.1% for the PS stent (P =0.636). Using Kaplan-Meier estimates, the incidence of clinically driven TLR was 8.9% for the MSII and 9.2% for the PS stent at 180 days; at 270 days, it was 12.8% and 12.1%, respectively (P = 0.83). MSII and the PS stents were comparable with respect to short-term procedural success, complications, and late clinical and angiographic restenosis. (C) 2001 Wiley-Liss, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 08:59:57